ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

Blackburn Wins BMS Award

May 23, 2003

NCI News Roundup: clinical Trials Initiatives Explained in Lectures Available Online

June 11, 1999

House Members Who Voted for Veto

January 3, 1986

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

Trials Approved by NCI CTEP For the Month of April

April 27, 2012

Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers

April 29, 1994